LithCTx - Combination drug therapy to prevent esophageal and lung cancers and cancer recurrence - Licensing Opportunity from University College Cork - September 2015 front page preview

LithCTx - Combination drug therapy to prevent esophageal and lung cancers and cancer recurrence - Licensing Opportunity from University College Cork - September 2015

A combination drug treatment comprising a chemotherapeutic drug and an autophagy inducing drug results in not only inhibition in the progression of cancer but also prevents the recurrence of cancer which may occur follow...

pdf 196.9KB

MirStent- cardiac repair therapy following heart attack - Licensing Opportunity from University College Cork - September 2015 front page preview

MirStent- cardiac repair therapy following heart attack - Licensing Opportunity from University College Cork - September 2015

After suffering a heart attack (i.e. STEMI type), a single dose IGF-1 therapy is effective in decreasing the size of the infarct (dead heart tissue) by at least 60%. Considering extensive use of stents in coronary angiop...

pdf 308.9KB

IL­‐36 Proteolytic Processing Inhibitors front page preview

IL­‐36 Proteolytic Processing Inhibitors

The development of a new and novel polypeptide entity that is capable of blocking the enzymes that promote inflammation of the skin such as psoriasis.

pdf 341.7KB

Compact, Light Weight, Fuel Cell Power Module with Reduced Manufacturing Cost - Licensing Opportunity from Dublin City University - August 2015 front page preview

Compact, Light Weight, Fuel Cell Power Module with Reduced Manufacturing Cost - Licensing Opportunity from Dublin City University - August 2015

Fuel cells are an attractive source of power for portable electronic devices, automotive and utility vehicles and power back-up. They convert a fuel, such as hydrogen, into electricity in a clean and efficient manner. Th...

pdf 2.1MB

Ground Breaking Discovery into the Causes of Amyotrophic Lateral Sclerosis (ALS) - Licensing Opportunity from Royal College of Surgeons in Ireland - July 2015 front page preview

Ground Breaking Discovery into the Causes of Amyotrophic Lateral Sclerosis (ALS) - Licensing Opportunity from Royal College of Surgeons in Ireland - July 2015

Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disorder of young and middle aged adults that is incurable and invariably fatal. Novel disease‐ specific mutations in a particular gene have recen...

pdf 318.3KB